Madrigal can compound Rezdiffra sales through rising MASH diagnosis, treatment adoption, and international expansion, but single-drug dependence, emerging competition, and demanding profitability expectations constrain its risk-adjusted appeal.
Entegris benefits from rising semiconductor materials intensity, strong process-level switching costs, and improving cash generation, but elevated valuation and acquisition-related leverage limit the margin of safety.
Qnity benefits from durable semiconductor materials qualifications and rising advanced packaging complexity, but its valuation, separation-related debt, and cyclical customer demand limit the current margin of safety.
BrightSpring benefits from expanding specialty pharmacy demand, growing home-health operations, and improving cash generation, although reimbursement exposure and demanding earnings expectations limit its margin of safety.
DT Midstream offers durable contracted natural gas infrastructure cash flows and growth from power demand, but elevated valuation and capital-intensive expansion limit its margin of safety.
Blue Owl's recurring private-market fees, growing AUM, and high dividend yield offer an attractive long-term income-and-growth opportunity, but private-credit risks, substantial equity compensation, and dilution threaten per-share returns.
WESCO combines expanding data center infrastructure demand with improving distribution margins and a record backlog, but its elevated historical valuation and working-capital intensity limit the margin of safety.
Alignment Healthcare has substantial long-term Medicare Advantage growth potential through differentiated senior-care delivery, but worsening medical costs and reduced profit guidance threaten the conversion of membership gains into durable earnings.
Allegro MicroSystems can benefit from expanding demand for specialized sensing and power semiconductors, but cyclical automotive exposure, intense competition, and demanding cash-flow valuation limit its margin of safety.
Madison Air benefits from structural demand for advanced cooling and engineered air quality products, supported by a large commercial backlog, but acquisition-related dilution, leverage, and integration risks constrain near-term shareholder returns.
Alnylam combines a differentiated RNAi platform, substantial ATTR growth potential, and positive cash flow at a more attractive valuation, but slower AMVUTTRA demand conversion and reimbursement risks threaten the pace of future expansion.
Eaton is a high-quality power-management franchise positioned for years of electrification and data-center infrastructure growth, but its elevated valuation and acquisition-related leverage limit near-term risk-adjusted upside.